REGISTERED NUMBER: 08941639 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 MARCH 2025

FOR

GLOW DERMATOLOGY LTD

Page

Balance Sheet

1

Notes to the Financial Statements

3

FIXED ASSETS

Tangible assets

5

51,398

64,459

CURRENT ASSETS

Debtors

6

696,437

560,064

Cash at bank

541,636

510,040

1,238,073

1,070,104

CREDITORS

Amounts falling due within one year

7

105,390

92,864

NET CURRENT ASSETS

1,132,683

977,240

TOTAL ASSETS LESS CURRENT LIABILITIES

1,184,081

1,041,699

CREDITORS

Amounts falling due after more than one year

8

(22,424

)

(29,970

)

PROVISIONS FOR LIABILITIES

9

(12,850

)

(16,115

)

NET ASSETS

1,148,807

995,614

CAPITAL AND RESERVES

Called up share capital

10

100

100

Retained earnings

1,148,707

995,514

SHAREHOLDERS' FUNDS

1,148,807

995,614

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 December 2025 and were signed on its behalf by:

Dr B S Shergill - Director

1.	STATUTORY INFORMATION

Glow Dermatology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

08941639

Registered office:

48 St Leonards Road

Bexhill on Sea

East Sussex

TN40 1JB

The presentation currency of the financial statements is the Pound Sterling (£).

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

The turnover shown in the profit and loss account represents amounts receivable for services provided during the year.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Fixtures, fittings and equipment

-

15% on reducing balance

Motor vehicles

-

25% on reducing balance

Computer equipment

-

33% on cost

All fixed assets are initially recorded at cost.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 3 ) .

5.	TANGIBLE FIXED ASSETS

Fixtures,

fittings

and

Motor

Computer

equipment

vehicles

equipment

Totals

£

£

£

£

COST

At 1 April 2024

38,377

45,269

37,925

121,571

Additions

766

-

229

995

Disposals

(2,550

)

-

(3,412

)

(5,962

)

At 31 March 2025

36,593

45,269

34,742

116,604

DEPRECIATION

At 1 April 2024

11,952

11,317

33,843

57,112

Charge for year

4,324

8,488

612

13,424

Eliminated on disposal

(1,918

)

-

(3,412

)

(5,330

)

At 31 March 2025

14,358

19,805

31,043

65,206

NET BOOK VALUE

At 31 March 2025

22,235

25,464

3,699

51,398

At 31 March 2024

26,425

33,952

4,082

64,459

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Motor

vehicles

£

COST

At 1 April 2024

and 31 March 2025

45,269

DEPRECIATION

At 1 April 2024

11,317

Charge for year

8,488

At 31 March 2025

19,805

NET BOOK VALUE

At 31 March 2025

25,464

At 31 March 2024

33,952

6.

DEBTORS

2025

2024

£

£

Amounts falling due within one year:

Trade debtors

81,771

34,666

Directors' current account

4,077

-

Prepayments and accrued income

6,355

8,627

92,203

43,293

Amounts falling due after more than one year:

Loan to Daysim Ltd

604,234

516,771

Aggregate amounts

696,437

560,064

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Hire purchase contracts

7,546

7,546

Trade creditors

3,715

5,600

Corporation tax

90,583

67,007

PAYE and social security

411

1,242

Directors' current account

-

8,453

Accruals and deferred income

3,135

3,016

105,390

92,864

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Hire purchase contracts

22,424

29,970

9.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

Accelerated capital allowances

12,850

16,115

Deferred

tax

£

Balance at 1 April 2024

16,115

Provided during year

(3,265

)

Balance at 31 March 2025

12,850

10.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

100

Ordinary

£1

100

100

11.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

Amounts due from directors at the balance sheet date total £4,076.76 (2024: £Nil). Amounts due are interest-free, unsecured, and repayable on demand.